Literature DB >> 15575912

Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients.

Wolfgang C Winkelmayer1, Matthias Lorenz, Reinhard Kramar, Walter H Hörl, Gere Sunder-Plassmann.   

Abstract

There are no published studies on the associations between anemia or iron status parameters and important long-term outcomes in kidney transplant recipients (KTR). We prospectively studied 438 KTR from a large transplant clinic for all-cause mortality and kidney allograft loss. Hemoglobin and iron status parameters (serum iron, transferrin, transferrin saturation, ferritin, percentage of hypochromic red blood cells [%HRBC]) were assessed at baseline as were important demographic, clinical and laboratory characteristics. The Austrian Dialysis and Transplant Registry and the Eurotransplant database were used to ascertain immunological and transplantation-related parameters and to ascertain death and allograft rejection. Cox proportional hazard models were used for analyses. Over 7.8 years of follow-up, 129 deaths (29.5%) occurred and 208 grafts (47.5%) were lost. From multivariate analyses, we found that anemia (hemoglobin <10g/dL) was not associated with mortality or graft loss. Among the iron status parameters, only %HRBC was associated with greater all-cause mortality. Patients with HRBC >10% had twice the mortality risk (HR: 2.06; 95%CI: 1.12-3.79) compared to patients with HRBC <5%. Neither of the iron status parameters were associated with allograft rejection. In conclusion, we found that %HRBC was an independent risk factor for mortality in KTR, while other iron status parameters or anemia were not associated with risk. Larger studies on the association between anemia and these outcomes are warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575912     DOI: 10.1046/j.1600-6143.2004.00604.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Pottransplantation anemia: management and rationale.

Authors:  Wolfgang C Winkelmayer; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

2.  Anemia at one year is an independent risk factor of graft survival.

Authors:  Luís Gustavo Modelli de Andrade; Juliana Maria Gera Abrão; Maria Fernanda Cordeiro Carvalho
Journal:  Int Urol Nephrol       Date:  2010-12-14       Impact factor: 2.370

3.  Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience.

Authors:  Osama Gheith; Ehab Wafa; Nabil Hassan; Amani Mostafa; Hussein A Sheashaa; Khaled Mahmoud; Ahmed Shokeir; Mohamed A Ghoneim
Journal:  Clin Exp Nephrol       Date:  2009-04-07       Impact factor: 2.801

4.  Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes.

Authors:  Zhongli Huang; Turun Song; Lei Fu; Zhengsheng Rao; Dongyang Zeng; Yang Qiu; Xianding Wang; Libo Xie; Qiang Wei; Li Wang; Tao Lin
Journal:  Int Urol Nephrol       Date:  2015-08-06       Impact factor: 2.370

5.  Post renal transplant anemia: severity, causes and their association with graft and patient survival.

Authors:  Amir Schechter; Anat Gafter-Gvili; Daniel Shepshelovich; Ruth Rahamimov; Uzi Gafter; Eytan Mor; Avry Chagnac; Benaya Rozen-Zvi
Journal:  BMC Nephrol       Date:  2019-02-13       Impact factor: 2.388

6.  Iron deficiency after kidney transplantation.

Authors:  Joanna Sophia J Vinke; Marith I Francke; Michele F Eisenga; Dennis A Hesselink; Martin H de Borst
Journal:  Nephrol Dial Transplant       Date:  2021-11-09       Impact factor: 5.992

7.  Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.

Authors:  Panagiota Xanthouli; Vivienne Theobald; Nicola Benjamin; Alberto M Marra; Anna D'Agostino; Benjamin Egenlauf; Memoona Shaukat; Cao Ding; Antonio Cittadini; Eduardo Bossone; Maria Kögler; Ekkehard Grünig; Martina U Muckenthaler; Christina A Eichstaedt
Journal:  Respir Res       Date:  2021-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.